KYM-1 (Q54900787)

From Wikidata

Jump to navigation Jump to search

cell line

Kym-1
KYM1

Language	Label	Description	Also known as
English	KYM-1	cell line	Kym-1 KYM1

Statements

1 reference

Cellosaurus release 44

23 January 2023

cancer cell line

1 reference

Cellosaurus release 44

23 January 2023

contaminated/misidentified cell line

1 reference

Cellosaurus release 44

23 January 2023

described by source

A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line

1 reference

Cellosaurus release 44

23 January 2023

Characterization of a human rhabdomyosarcoma cell strain in tissue culture.

1 reference

Cellosaurus release 44

23 January 2023

Screening the p53 status of human cell lines using a yeast functional assay

1 reference

Cellosaurus release 44

23 January 2023

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers

1 reference

Cellosaurus release 44

23 January 2023

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

Cellosaurus release 44

23 January 2023

Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays

1 reference

Cellosaurus release 44

23 January 2023

A landscape of pharmacogenomic interactions in cancer.

1 reference

Cellosaurus release 44

23 January 2023

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 44

23 January 2023

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 44

23 January 2023

Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

1 reference

Cellosaurus release 44

23 January 2023

Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors

1 reference

Cellosaurus release 44

23 January 2023

Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.

1 reference

Cellosaurus release 44

23 January 2023

Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas

1 reference

Cellosaurus release 44

23 January 2023

Cetuximab promotes anticancer drug toxicity in rhabdomyosarcomas with EGFR amplification in vitro

1 reference

Cellosaurus release 44

23 January 2023

Assessing alveolar rhabdomyosarcoma cell lines as tumor models by comparison of mRNA expression profiles

1 reference

Cellosaurus release 44

23 January 2023

established from medical condition

embryonal rhabdomyosarcoma

1 reference

Cellosaurus release 44

23 January 2023

derived from organism type

1 reference

Cellosaurus release 44

23 January 2023

Identifiers

1 reference

Cellosaurus release 44

23 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54900787&oldid=1861530558"